Moreover, DSS analyses showed that high ASF1B expression predicted adverse outcomes in individuals (Figure 3A) with ACC (p < 0.001), CESC (p = 0.003), KICH (p < 0.001), KIRC (p < 0.001), KIRP (p < 0.001), LGG (p < 0.001), LIHC (p = 0.034), LUAD (p = 0.0018), LUSC (p = 0.030), MESO (p < 0.001), PAAD (p < 0.001), PCPG (p = 0.002), PRAD (p = 0.002), and UVM (p = 0.0039). The gene discussed is ASF1B; the disease is adrenal cortex carcinoma.